{
    "medicine_id": "cf493e1c26fbf0401a5d36f50faf4fa58f2b408c",
    "platform_id": "DB09270",
    "metadata": {
        "name": "Acti ubiquinone 50 Cap 50mg 25 mg Capsule",
        "composition": "25 mg Ubidecarenone",
        "clinical_particulars": {
            "therapeutic_indications": "The diet supplements containing ubidecarenone are indicated as stated in the product label to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension In the product ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson fibromyalgia migraine periodontal disease and diabetes based on preclinical studies L1064 It is important to highlight that these products are not FDA approved and it is recommended to use under discretion",
            "contraindications": {
                "disease": "There have not been reports of adverse events of diet supplementation with ubidecarenone A31417 The normal side effects reported in humans are related to the gastrointestinal tract A31416",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ubidecarenon has roles in many prysiological process including sulfide oxidation regulation of mitochondrial permeability transition pore and translocation of protons and calcium ions accross biological membranes Studies have shown its benefitial effect in treating cancer statin myopathy congestive heart failure and hypertension A31413",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00071",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Metformin"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Phenformin"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gliquidone"
                    },
                    {
                        "drugbank-id": "DB01252",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mitiglinide"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glisoxepide"
                    },
                    {
                        "drugbank-id": "DB01382",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glymidine"
                    },
                    {
                        "drugbank-id": "DB01700",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with AICA ribonucleotide"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Buformin"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Vildagliptin"
                    },
                    {
                        "drugbank-id": "DB04878",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Voglibose"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with NN344"
                    },
                    {
                        "drugbank-id": "DB05819",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with NBI 6024"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with AMG 222"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Bisegliptin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Alogliptin"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gosogliptin"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glibornuride"
                    },
                    {
                        "drugbank-id": "DB09022",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Benfluorex"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB09043",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Albiglutide"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Netoglitazone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Rivoglitazone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ciglitazone"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Lixisenatide"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin beef"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB11698",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ipragliflozin"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Dutogliptin"
                    },
                    {
                        "drugbank-id": "DB11780",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Allicin"
                    },
                    {
                        "drugbank-id": "DB11824",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Tofogliflozin"
                    },
                    {
                        "drugbank-id": "DB11898",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with 2 4 thiazolidinedione"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Teneligliptin"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Omarigliptin"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Carmegliptin"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gemigliptin"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Anagliptin"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Evogliptin"
                    },
                    {
                        "drugbank-id": "DB12713",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sotagliflozin"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Balaglitazone"
                    },
                    {
                        "drugbank-id": "DB12935",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Remogliflozin etabonate"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Carbutamide"
                    },
                    {
                        "drugbank-id": "DB13446",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Guar gum"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Metahexamide"
                    },
                    {
                        "drugbank-id": "DB13928",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Semaglutide"
                    },
                    {
                        "drugbank-id": "DB14027",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Taspoglutide"
                    },
                    {
                        "drugbank-id": "DB14035",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Englitazone"
                    },
                    {
                        "drugbank-id": "DB15171",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Tirzepatide"
                    },
                    {
                        "drugbank-id": "DB15217",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gastric inhibitory polypeptide"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "The risk or severity of hypoglycemia can be increased when Acarbose is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00491",
                        "description": "The risk or severity of hypoglycemia can be increased when Miglitol is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The risk or severity of hypoglycemia can be increased when Chlorpropamide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of hypoglycemia can be increased when Pentamidine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The risk or severity of hypoglycemia can be increased when Glipizide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The risk or severity of hypoglycemia can be increased when Tolbutamide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01276",
                        "description": "The risk or severity of hypoglycemia can be increased when Exenatide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01277",
                        "description": "The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01306",
                        "description": "The risk or severity of hypoglycemia can be increased when Insulin aspart is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01307",
                        "description": "The risk or severity of hypoglycemia can be increased when Insulin detemir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "The risk or severity of hypoglycemia can be increased when Insulin glulisine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB06655",
                        "description": "The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of hypoglycemia can be increased when Pasireotide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The risk or severity of hypoglycemia can be increased when Lanreotide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB14025",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Clinafloxacin"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of hypoglycemia can be increased when Octreotide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of hypoglycemia can be increased when Citalopram is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of hypoglycemia can be increased when Sertraline is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The therapeutic efficacy of Phenindione can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The therapeutic efficacy of Warfarin can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The therapeutic efficacy of 4 hydroxycoumarin can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The therapeutic efficacy of Coumarin can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The therapeutic efficacy of R warfarin can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The therapeutic efficacy of Fluindione can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The therapeutic efficacy of Clorindione can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The therapeutic efficacy of Diphenadione can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The therapeutic efficacy of Tioclomarol can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The therapeutic efficacy of S Warfarin can be decreased when used in combination with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB06693",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Pitavastatin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of cardiotoxicity can be decreased when Ubidecarenone is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The therapeutic efficacy of Ubidecarenone can be decreased when used in combination with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The therapeutic efficacy of Ubidecarenone can be decreased when used in combination with Propranolol"
                    },
                    {
                        "drugbank-id": "DB12582",
                        "description": "The serum concentration of Ubidecarenone can be increased when it is combined with Piperine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leuprolide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00052",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Somatotropin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Infliximab is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Daptomycin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Baclofen is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sildenafil is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cladribine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Phenytoin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pamidronic acid is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Carbimazole is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Betamethasone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Montelukast is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Zidovudine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lercanidipine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofloxacin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propylthiouracil is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methotrexate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Enalapril is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nizatidine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triamcinolone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Alendronic acid is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Clofibrate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Stavudine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00666",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Amphotericin B is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mycophenolate mofetil is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lamivudine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ibandronate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Terbinafine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Penicillamine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Eprosartan is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Risedronic acid is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Bumetanide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triazolam is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ethanol is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Salmeterol is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Isoniazid is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methyldopa is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Isotretinoin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cytarabine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ganciclovir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Letrozole is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sulfamethoxazole is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Minocycline is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Procainamide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Norfloxacin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Iloprost is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leflunomide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ofloxacin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Procarbazine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Metoclopramide is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Gemfibrozil is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Docetaxel is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Bezafibrate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Fusidic acid is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trabectedin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Etofibrate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB09055",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Acipimox is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofibrate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Ipecac"
                    },
                    {
                        "drugbank-id": "DB13393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Emetine"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Simfibrate"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Ronifibrate"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Aluminium clofibrate"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Clofibride"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ubidecarenone is combined with Fenofibric acid"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cyclosporine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Indinavir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mefloquine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trimethoprim is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cimetidine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ritonavir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Vincristine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ivermectin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Chloroquine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propofol is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ranitidine is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrolimus is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Fenofibrate is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Amiodarone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Captopril is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Paclitaxel is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Saquinavir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Dexamethasone is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Colchicine is combined with Ubidecarenone"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}